Taiflex Scientific Co., Ltd. (TPE:8039)
Taiwan · Delayed Price · Currency is TWD 291.50
+26.50 (10.00%)
Aug 25, 2026, 1:30 PM CST
Taiflex Scientific Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 69,872 | 21,876 | 10,492 | 10,257 | 8,616 | 9,933 | |
Market Cap Growth | 454.47% | 108.51% | 2.29% | 19.05% | -13.26% | -13.00% |
Enterprise Value | 67,376 | 21,007 | 9,005 | 11,207 | 9,663 | 10,558 |
Last Close Price | 265.00 | 83.97 | 41.96 | 43.19 | 34.22 | 37.17 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 83.95 | 40.88 | 17.70 | 24.25 | 12.30 | 13.52 |
Forward PE | - | 13.98 | 17.05 | 10.83 | 11.38 | 10.90 |
PS Ratio | 6.51 | 2.06 | 1.06 | 1.26 | 0.99 | 1.06 |
PB Ratio | 6.22 | 2.00 | 0.98 | 1.27 | 1.07 | 1.25 |
P/TBV Ratio | 6.32 | 2.03 | 1.00 | 1.31 | 1.11 | 1.31 |
P/FCF Ratio | 75.28 | 194.17 | 14.42 | 39.96 | 52.33 | - |
P/OCF Ratio | 46.99 | 30.92 | 7.39 | 8.07 | 7.55 | 43.52 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.28 | 1.98 | 0.91 | 1.38 | 1.11 | 1.12 |
EV/EBITDA Ratio | 60.47 | 21.14 | 7.89 | 12.51 | 9.34 | 8.11 |
EV/EBIT Ratio | 120.35 | 42.67 | 13.59 | 22.98 | 14.91 | 11.13 |
EV/FCF Ratio | 72.59 | 186.45 | 12.38 | 43.66 | 58.69 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.08 | 0.11 | 0.34 | 0.35 | 0.47 |
Debt / EBITDA Ratio | 1.27 | 0.90 | 0.98 | 2.98 | 2.63 | 2.81 |
Debt / FCF Ratio | 1.53 | 8.16 | 1.59 | 10.75 | 16.91 | - |
Net Debt / Equity Ratio | -0.22 | -0.18 | -0.18 | 0.10 | 0.06 | 0.02 |
Net Debt / EBITDA Ratio | -2.34 | -2.01 | -1.72 | 0.86 | 0.45 | 0.12 |
Net Debt / FCF Ratio | -2.72 | -17.71 | -2.70 | 2.99 | 2.81 | -0.50 |
Asset Turnover | 0.68 | 0.72 | 0.72 | 0.63 | 0.65 | 0.74 |
Inventory Turnover | 3.67 | 4.94 | 5.10 | 4.00 | 3.65 | 4.57 |
Quick Ratio | 1.83 | 2.31 | 2.48 | 1.43 | 2.93 | 2.59 |
Current Ratio | 2.38 | 2.94 | 3.11 | 1.80 | 3.82 | 3.26 |
Return on Equity (ROE) | 7.90% | 4.86% | 5.68% | 4.47% | 8.67% | 9.62% |
Return on Assets (ROA) | 2.22% | 2.10% | 3.01% | 2.35% | 3.01% | 4.63% |
Return on Invested Capital (ROIC) | 5.41% | 4.77% | 5.74% | 4.20% | 6.17% | 10.20% |
Return on Capital Employed (ROCE) | 4.60% | 4.20% | 5.70% | 5.50% | 6.00% | 8.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.19% | 2.45% | 5.65% | 4.12% | 8.13% | 7.40% |
FCF Yield | 1.33% | 0.52% | 6.93% | 2.50% | 1.91% | -3.03% |
Dividend Yield | 0.74% | 2.38% | 5.96% | 2.04% | 6.98% | 6.43% |
Payout Ratio | 77.04% | 119.73% | 35.28% | 123.60% | 74.63% | 71.16% |
Buyback Yield / Dilution | -0.85% | -1.68% | 1.43% | -0.83% | -0.92% | -17.36% |
Total Shareholder Return | -0.11% | 0.70% | 7.39% | 1.21% | 6.07% | -10.93% |